nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—Mental disability—Epirubicin—liver cancer	0.00209	0.00232	CcSEcCtD
Tizanidine—Dyspnoea—Sorafenib—liver cancer	0.00207	0.0023	CcSEcCtD
Tizanidine—Dyspepsia—Sorafenib—liver cancer	0.00204	0.00227	CcSEcCtD
Tizanidine—Phlebitis—Epirubicin—liver cancer	0.00202	0.00226	CcSEcCtD
Tizanidine—Ecchymosis—Doxorubicin—liver cancer	0.00201	0.00224	CcSEcCtD
Tizanidine—Bladder pain—Doxorubicin—liver cancer	0.00201	0.00224	CcSEcCtD
Tizanidine—Fatigue—Sorafenib—liver cancer	0.002	0.00223	CcSEcCtD
Tizanidine—Hepatic function abnormal—Epirubicin—liver cancer	0.002	0.00222	CcSEcCtD
Tizanidine—Constipation—Sorafenib—liver cancer	0.00198	0.00221	CcSEcCtD
Tizanidine—Pulmonary oedema—Doxorubicin—liver cancer	0.00198	0.0022	CcSEcCtD
Tizanidine—Vascular purpura—Epirubicin—liver cancer	0.00195	0.00217	CcSEcCtD
Tizanidine—Hypertonia—Doxorubicin—liver cancer	0.00195	0.00217	CcSEcCtD
Tizanidine—Hepatic failure—Epirubicin—liver cancer	0.00194	0.00216	CcSEcCtD
Tizanidine—Eye pain—Epirubicin—liver cancer	0.00193	0.00215	CcSEcCtD
Tizanidine—Sepsis—Doxorubicin—liver cancer	0.00193	0.00215	CcSEcCtD
Tizanidine—Mental disability—Doxorubicin—liver cancer	0.00193	0.00215	CcSEcCtD
Tizanidine—Gastrointestinal pain—Sorafenib—liver cancer	0.0019	0.00211	CcSEcCtD
Tizanidine—Renal failure acute—Epirubicin—liver cancer	0.00189	0.0021	CcSEcCtD
Tizanidine—Phlebitis—Doxorubicin—liver cancer	0.00187	0.00209	CcSEcCtD
Tizanidine—Dermatitis exfoliative—Epirubicin—liver cancer	0.00185	0.00206	CcSEcCtD
Tizanidine—Hepatic function abnormal—Doxorubicin—liver cancer	0.00185	0.00206	CcSEcCtD
Tizanidine—Urticaria—Sorafenib—liver cancer	0.00184	0.00205	CcSEcCtD
Tizanidine—Body temperature increased—Sorafenib—liver cancer	0.00183	0.00204	CcSEcCtD
Tizanidine—Abdominal pain—Sorafenib—liver cancer	0.00183	0.00204	CcSEcCtD
Tizanidine—Purpura—Epirubicin—liver cancer	0.00181	0.00202	CcSEcCtD
Tizanidine—Vascular purpura—Doxorubicin—liver cancer	0.0018	0.00201	CcSEcCtD
Tizanidine—Hepatic failure—Doxorubicin—liver cancer	0.0018	0.002	CcSEcCtD
Tizanidine—Eye pain—Doxorubicin—liver cancer	0.00179	0.00199	CcSEcCtD
Tizanidine—Cardiac failure—Epirubicin—liver cancer	0.00179	0.00199	CcSEcCtD
Tizanidine—Cerebrovascular accident—Epirubicin—liver cancer	0.00178	0.00198	CcSEcCtD
Tizanidine—Hyponatraemia—Epirubicin—liver cancer	0.00175	0.00195	CcSEcCtD
Tizanidine—Renal failure acute—Doxorubicin—liver cancer	0.00175	0.00195	CcSEcCtD
Tizanidine—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00174	0.00194	CcSEcCtD
Tizanidine—Migraine—Epirubicin—liver cancer	0.00172	0.00191	CcSEcCtD
Tizanidine—Affect lability—Epirubicin—liver cancer	0.00172	0.00191	CcSEcCtD
Tizanidine—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00171	0.00191	CcSEcCtD
Tizanidine—Hypersensitivity—Sorafenib—liver cancer	0.00171	0.0019	CcSEcCtD
Tizanidine—Purpura—Doxorubicin—liver cancer	0.00167	0.00187	CcSEcCtD
Tizanidine—Asthenia—Sorafenib—liver cancer	0.00166	0.00185	CcSEcCtD
Tizanidine—Cardiac arrest—Epirubicin—liver cancer	0.00166	0.00185	CcSEcCtD
Tizanidine—Cardiac failure—Doxorubicin—liver cancer	0.00165	0.00184	CcSEcCtD
Tizanidine—Mood swings—Epirubicin—liver cancer	0.00165	0.00184	CcSEcCtD
Tizanidine—Cerebrovascular accident—Doxorubicin—liver cancer	0.00165	0.00183	CcSEcCtD
Tizanidine—Pruritus—Sorafenib—liver cancer	0.00164	0.00183	CcSEcCtD
Tizanidine—Hyponatraemia—Doxorubicin—liver cancer	0.00162	0.00181	CcSEcCtD
Tizanidine—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00161	0.0018	CcSEcCtD
Tizanidine—Liver function test abnormal—Epirubicin—liver cancer	0.00161	0.00179	CcSEcCtD
Tizanidine—Dry skin—Epirubicin—liver cancer	0.0016	0.00178	CcSEcCtD
Tizanidine—Orthostatic hypotension—Epirubicin—liver cancer	0.00159	0.00177	CcSEcCtD
Tizanidine—Affect lability—Doxorubicin—liver cancer	0.00159	0.00177	CcSEcCtD
Tizanidine—Migraine—Doxorubicin—liver cancer	0.00159	0.00177	CcSEcCtD
Tizanidine—Hypokalaemia—Epirubicin—liver cancer	0.00159	0.00177	CcSEcCtD
Tizanidine—Diarrhoea—Sorafenib—liver cancer	0.00159	0.00177	CcSEcCtD
Tizanidine—Muscular weakness—Epirubicin—liver cancer	0.00154	0.00171	CcSEcCtD
Tizanidine—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00154	0.00171	CcSEcCtD
Tizanidine—Cardiac arrest—Doxorubicin—liver cancer	0.00153	0.00171	CcSEcCtD
Tizanidine—Dizziness—Sorafenib—liver cancer	0.00153	0.00171	CcSEcCtD
Tizanidine—Mood swings—Doxorubicin—liver cancer	0.00153	0.0017	CcSEcCtD
Tizanidine—Asthma—Epirubicin—liver cancer	0.00151	0.00168	CcSEcCtD
Tizanidine—Dysphagia—Epirubicin—liver cancer	0.00151	0.00168	CcSEcCtD
Tizanidine—Influenza—Epirubicin—liver cancer	0.00151	0.00168	CcSEcCtD
Tizanidine—Liver function test abnormal—Doxorubicin—liver cancer	0.00149	0.00166	CcSEcCtD
Tizanidine—Dry skin—Doxorubicin—liver cancer	0.00148	0.00165	CcSEcCtD
Tizanidine—Vomiting—Sorafenib—liver cancer	0.00147	0.00164	CcSEcCtD
Tizanidine—Orthostatic hypotension—Doxorubicin—liver cancer	0.00147	0.00164	CcSEcCtD
Tizanidine—Hypokalaemia—Doxorubicin—liver cancer	0.00147	0.00164	CcSEcCtD
Tizanidine—Angina pectoris—Epirubicin—liver cancer	0.00147	0.00164	CcSEcCtD
Tizanidine—Rash—Sorafenib—liver cancer	0.00146	0.00163	CcSEcCtD
Tizanidine—Dermatitis—Sorafenib—liver cancer	0.00146	0.00163	CcSEcCtD
Tizanidine—Bronchitis—Epirubicin—liver cancer	0.00145	0.00162	CcSEcCtD
Tizanidine—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00142	0.00159	CcSEcCtD
Tizanidine—Muscular weakness—Doxorubicin—liver cancer	0.00142	0.00159	CcSEcCtD
Tizanidine—Asthma—Doxorubicin—liver cancer	0.00139	0.00155	CcSEcCtD
Tizanidine—Dysphagia—Doxorubicin—liver cancer	0.00139	0.00155	CcSEcCtD
Tizanidine—Influenza—Doxorubicin—liver cancer	0.00139	0.00155	CcSEcCtD
Tizanidine—Pollakiuria—Epirubicin—liver cancer	0.00139	0.00155	CcSEcCtD
Tizanidine—Nausea—Sorafenib—liver cancer	0.00138	0.00153	CcSEcCtD
Tizanidine—Weight decreased—Epirubicin—liver cancer	0.00136	0.00152	CcSEcCtD
Tizanidine—Hyperglycaemia—Epirubicin—liver cancer	0.00136	0.00151	CcSEcCtD
Tizanidine—Angina pectoris—Doxorubicin—liver cancer	0.00136	0.00151	CcSEcCtD
Tizanidine—Pneumonia—Epirubicin—liver cancer	0.00135	0.00151	CcSEcCtD
Tizanidine—Drowsiness—Epirubicin—liver cancer	0.00134	0.0015	CcSEcCtD
Tizanidine—Bronchitis—Doxorubicin—liver cancer	0.00134	0.00149	CcSEcCtD
Tizanidine—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00133	0.00148	CcSEcCtD
Tizanidine—Renal failure—Epirubicin—liver cancer	0.00132	0.00147	CcSEcCtD
Tizanidine—Neuropathy peripheral—Epirubicin—liver cancer	0.00132	0.00147	CcSEcCtD
Tizanidine—Jaundice—Epirubicin—liver cancer	0.00131	0.00146	CcSEcCtD
Tizanidine—Conjunctivitis—Epirubicin—liver cancer	0.00131	0.00146	CcSEcCtD
Tizanidine—Sweating—Epirubicin—liver cancer	0.00129	0.00144	CcSEcCtD
Tizanidine—Pollakiuria—Doxorubicin—liver cancer	0.00129	0.00144	CcSEcCtD
Tizanidine—Haematuria—Epirubicin—liver cancer	0.00128	0.00143	CcSEcCtD
Tizanidine—Hepatobiliary disease—Epirubicin—liver cancer	0.00127	0.00142	CcSEcCtD
Tizanidine—Weight decreased—Doxorubicin—liver cancer	0.00126	0.00141	CcSEcCtD
Tizanidine—Sinusitis—Epirubicin—liver cancer	0.00126	0.0014	CcSEcCtD
Tizanidine—Hyperglycaemia—Doxorubicin—liver cancer	0.00126	0.0014	CcSEcCtD
Tizanidine—Agranulocytosis—Epirubicin—liver cancer	0.00125	0.0014	CcSEcCtD
Tizanidine—Pneumonia—Doxorubicin—liver cancer	0.00125	0.00139	CcSEcCtD
Tizanidine—Drowsiness—Doxorubicin—liver cancer	0.00124	0.00139	CcSEcCtD
Tizanidine—Clonidine—CYP1A1—liver cancer	0.00124	1	CrCbGaD
Tizanidine—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00123	0.00137	CcSEcCtD
Tizanidine—Bradycardia—Epirubicin—liver cancer	0.00123	0.00137	CcSEcCtD
Tizanidine—Renal failure—Doxorubicin—liver cancer	0.00122	0.00136	CcSEcCtD
Tizanidine—Neuropathy peripheral—Doxorubicin—liver cancer	0.00122	0.00136	CcSEcCtD
Tizanidine—Haemoglobin—Epirubicin—liver cancer	0.00121	0.00135	CcSEcCtD
Tizanidine—Jaundice—Doxorubicin—liver cancer	0.00121	0.00135	CcSEcCtD
Tizanidine—Rhinitis—Epirubicin—liver cancer	0.00121	0.00135	CcSEcCtD
Tizanidine—Conjunctivitis—Doxorubicin—liver cancer	0.00121	0.00135	CcSEcCtD
Tizanidine—Hepatitis—Epirubicin—liver cancer	0.00121	0.00134	CcSEcCtD
Tizanidine—Haemorrhage—Epirubicin—liver cancer	0.00121	0.00134	CcSEcCtD
Tizanidine—Pharyngitis—Epirubicin—liver cancer	0.0012	0.00133	CcSEcCtD
Tizanidine—Sweating—Doxorubicin—liver cancer	0.00119	0.00133	CcSEcCtD
Tizanidine—Urinary tract disorder—Epirubicin—liver cancer	0.00119	0.00133	CcSEcCtD
Tizanidine—Haematuria—Doxorubicin—liver cancer	0.00119	0.00132	CcSEcCtD
Tizanidine—Connective tissue disorder—Epirubicin—liver cancer	0.00119	0.00132	CcSEcCtD
Tizanidine—Urethral disorder—Epirubicin—liver cancer	0.00118	0.00132	CcSEcCtD
Tizanidine—Hepatobiliary disease—Doxorubicin—liver cancer	0.00118	0.00131	CcSEcCtD
Tizanidine—Sinusitis—Doxorubicin—liver cancer	0.00117	0.0013	CcSEcCtD
Tizanidine—Agranulocytosis—Doxorubicin—liver cancer	0.00116	0.00129	CcSEcCtD
Tizanidine—Erythema multiforme—Epirubicin—liver cancer	0.00114	0.00127	CcSEcCtD
Tizanidine—Bradycardia—Doxorubicin—liver cancer	0.00114	0.00127	CcSEcCtD
Tizanidine—Tinnitus—Epirubicin—liver cancer	0.00113	0.00125	CcSEcCtD
Tizanidine—Haemoglobin—Doxorubicin—liver cancer	0.00112	0.00125	CcSEcCtD
Tizanidine—Cardiac disorder—Epirubicin—liver cancer	0.00112	0.00125	CcSEcCtD
Tizanidine—Rhinitis—Doxorubicin—liver cancer	0.00112	0.00125	CcSEcCtD
Tizanidine—Haemorrhage—Doxorubicin—liver cancer	0.00112	0.00124	CcSEcCtD
Tizanidine—Hepatitis—Doxorubicin—liver cancer	0.00112	0.00124	CcSEcCtD
Tizanidine—Pharyngitis—Doxorubicin—liver cancer	0.00111	0.00123	CcSEcCtD
Tizanidine—Urinary tract disorder—Doxorubicin—liver cancer	0.0011	0.00123	CcSEcCtD
Tizanidine—Connective tissue disorder—Doxorubicin—liver cancer	0.0011	0.00122	CcSEcCtD
Tizanidine—Angiopathy—Epirubicin—liver cancer	0.00109	0.00122	CcSEcCtD
Tizanidine—Urethral disorder—Doxorubicin—liver cancer	0.00109	0.00122	CcSEcCtD
Tizanidine—Immune system disorder—Epirubicin—liver cancer	0.00109	0.00121	CcSEcCtD
Tizanidine—Mediastinal disorder—Epirubicin—liver cancer	0.00109	0.00121	CcSEcCtD
Tizanidine—Arrhythmia—Epirubicin—liver cancer	0.00108	0.0012	CcSEcCtD
Tizanidine—Alopecia—Epirubicin—liver cancer	0.00107	0.00119	CcSEcCtD
Tizanidine—Mental disorder—Epirubicin—liver cancer	0.00106	0.00118	CcSEcCtD
Tizanidine—Erythema multiforme—Doxorubicin—liver cancer	0.00106	0.00118	CcSEcCtD
Tizanidine—Tinnitus—Doxorubicin—liver cancer	0.00104	0.00116	CcSEcCtD
Tizanidine—Cardiac disorder—Doxorubicin—liver cancer	0.00104	0.00115	CcSEcCtD
Tizanidine—Flatulence—Epirubicin—liver cancer	0.00104	0.00115	CcSEcCtD
Tizanidine—Tension—Epirubicin—liver cancer	0.00103	0.00115	CcSEcCtD
Tizanidine—Nervousness—Epirubicin—liver cancer	0.00102	0.00114	CcSEcCtD
Tizanidine—Back pain—Epirubicin—liver cancer	0.00102	0.00113	CcSEcCtD
Tizanidine—Angiopathy—Doxorubicin—liver cancer	0.00101	0.00113	CcSEcCtD
Tizanidine—Muscle spasms—Epirubicin—liver cancer	0.00101	0.00113	CcSEcCtD
Tizanidine—Immune system disorder—Doxorubicin—liver cancer	0.00101	0.00112	CcSEcCtD
Tizanidine—Mediastinal disorder—Doxorubicin—liver cancer	0.00101	0.00112	CcSEcCtD
Tizanidine—Arrhythmia—Doxorubicin—liver cancer	0.000997	0.00111	CcSEcCtD
Tizanidine—Vision blurred—Epirubicin—liver cancer	0.00099	0.0011	CcSEcCtD
Tizanidine—Alopecia—Doxorubicin—liver cancer	0.000987	0.0011	CcSEcCtD
Tizanidine—Mental disorder—Doxorubicin—liver cancer	0.000978	0.00109	CcSEcCtD
Tizanidine—Ill-defined disorder—Epirubicin—liver cancer	0.000975	0.00109	CcSEcCtD
Tizanidine—Anaemia—Epirubicin—liver cancer	0.000971	0.00108	CcSEcCtD
Tizanidine—Agitation—Epirubicin—liver cancer	0.000965	0.00108	CcSEcCtD
Tizanidine—Flatulence—Doxorubicin—liver cancer	0.000958	0.00107	CcSEcCtD
Tizanidine—Tension—Doxorubicin—liver cancer	0.000954	0.00106	CcSEcCtD
Tizanidine—Malaise—Epirubicin—liver cancer	0.000947	0.00106	CcSEcCtD
Tizanidine—Nervousness—Doxorubicin—liver cancer	0.000944	0.00105	CcSEcCtD
Tizanidine—Vertigo—Epirubicin—liver cancer	0.000944	0.00105	CcSEcCtD
Tizanidine—Syncope—Epirubicin—liver cancer	0.000942	0.00105	CcSEcCtD
Tizanidine—Leukopenia—Epirubicin—liver cancer	0.00094	0.00105	CcSEcCtD
Tizanidine—Back pain—Doxorubicin—liver cancer	0.00094	0.00105	CcSEcCtD
Tizanidine—Muscle spasms—Doxorubicin—liver cancer	0.000934	0.00104	CcSEcCtD
Tizanidine—Loss of consciousness—Epirubicin—liver cancer	0.000923	0.00103	CcSEcCtD
Tizanidine—Vision blurred—Doxorubicin—liver cancer	0.000916	0.00102	CcSEcCtD
Tizanidine—Convulsion—Epirubicin—liver cancer	0.00091	0.00101	CcSEcCtD
Tizanidine—Hypertension—Epirubicin—liver cancer	0.000907	0.00101	CcSEcCtD
Tizanidine—Ill-defined disorder—Doxorubicin—liver cancer	0.000902	0.001	CcSEcCtD
Tizanidine—Anaemia—Doxorubicin—liver cancer	0.000898	0.001	CcSEcCtD
Tizanidine—Arthralgia—Epirubicin—liver cancer	0.000894	0.000996	CcSEcCtD
Tizanidine—Agitation—Doxorubicin—liver cancer	0.000893	0.000995	CcSEcCtD
Tizanidine—Anxiety—Epirubicin—liver cancer	0.000891	0.000993	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000888	0.000989	CcSEcCtD
Tizanidine—Discomfort—Epirubicin—liver cancer	0.000884	0.000984	CcSEcCtD
Tizanidine—Malaise—Doxorubicin—liver cancer	0.000877	0.000976	CcSEcCtD
Tizanidine—Dry mouth—Epirubicin—liver cancer	0.000875	0.000974	CcSEcCtD
Tizanidine—Vertigo—Doxorubicin—liver cancer	0.000873	0.000973	CcSEcCtD
Tizanidine—Syncope—Doxorubicin—liver cancer	0.000872	0.000971	CcSEcCtD
Tizanidine—Leukopenia—Doxorubicin—liver cancer	0.00087	0.000969	CcSEcCtD
Tizanidine—Confusional state—Epirubicin—liver cancer	0.000864	0.000963	CcSEcCtD
Tizanidine—Anaphylactic shock—Epirubicin—liver cancer	0.000857	0.000955	CcSEcCtD
Tizanidine—Oedema—Epirubicin—liver cancer	0.000857	0.000955	CcSEcCtD
Tizanidine—Loss of consciousness—Doxorubicin—liver cancer	0.000854	0.000952	CcSEcCtD
Tizanidine—Infection—Epirubicin—liver cancer	0.000852	0.000949	CcSEcCtD
Tizanidine—Shock—Epirubicin—liver cancer	0.000843	0.00094	CcSEcCtD
Tizanidine—Convulsion—Doxorubicin—liver cancer	0.000842	0.000938	CcSEcCtD
Tizanidine—Nervous system disorder—Epirubicin—liver cancer	0.000841	0.000937	CcSEcCtD
Tizanidine—Thrombocytopenia—Epirubicin—liver cancer	0.000839	0.000935	CcSEcCtD
Tizanidine—Hypertension—Doxorubicin—liver cancer	0.000839	0.000935	CcSEcCtD
Tizanidine—Tachycardia—Epirubicin—liver cancer	0.000837	0.000932	CcSEcCtD
Tizanidine—Skin disorder—Epirubicin—liver cancer	0.000833	0.000928	CcSEcCtD
Tizanidine—Hyperhidrosis—Epirubicin—liver cancer	0.000829	0.000923	CcSEcCtD
Tizanidine—Arthralgia—Doxorubicin—liver cancer	0.000827	0.000922	CcSEcCtD
Tizanidine—Anxiety—Doxorubicin—liver cancer	0.000825	0.000919	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000822	0.000915	CcSEcCtD
Tizanidine—Discomfort—Doxorubicin—liver cancer	0.000818	0.000911	CcSEcCtD
Tizanidine—Dry mouth—Doxorubicin—liver cancer	0.000809	0.000902	CcSEcCtD
Tizanidine—Hypotension—Epirubicin—liver cancer	0.000801	0.000892	CcSEcCtD
Tizanidine—Confusional state—Doxorubicin—liver cancer	0.0008	0.000891	CcSEcCtD
Tizanidine—Oedema—Doxorubicin—liver cancer	0.000793	0.000884	CcSEcCtD
Tizanidine—Anaphylactic shock—Doxorubicin—liver cancer	0.000793	0.000884	CcSEcCtD
Tizanidine—Infection—Doxorubicin—liver cancer	0.000788	0.000878	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000781	0.00087	CcSEcCtD
Tizanidine—Shock—Doxorubicin—liver cancer	0.00078	0.000869	CcSEcCtD
Tizanidine—Nervous system disorder—Doxorubicin—liver cancer	0.000778	0.000867	CcSEcCtD
Tizanidine—Thrombocytopenia—Doxorubicin—liver cancer	0.000777	0.000865	CcSEcCtD
Tizanidine—Tachycardia—Doxorubicin—liver cancer	0.000774	0.000862	CcSEcCtD
Tizanidine—Skin disorder—Doxorubicin—liver cancer	0.000771	0.000858	CcSEcCtD
Tizanidine—Paraesthesia—Epirubicin—liver cancer	0.00077	0.000858	CcSEcCtD
Tizanidine—Hyperhidrosis—Doxorubicin—liver cancer	0.000767	0.000854	CcSEcCtD
Tizanidine—Dyspnoea—Epirubicin—liver cancer	0.000764	0.000851	CcSEcCtD
Tizanidine—Somnolence—Epirubicin—liver cancer	0.000762	0.000849	CcSEcCtD
Tizanidine—Dyspepsia—Epirubicin—liver cancer	0.000755	0.000841	CcSEcCtD
Tizanidine—Hypotension—Doxorubicin—liver cancer	0.000741	0.000826	CcSEcCtD
Tizanidine—Fatigue—Epirubicin—liver cancer	0.000739	0.000823	CcSEcCtD
Tizanidine—Constipation—Epirubicin—liver cancer	0.000733	0.000817	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000723	0.000805	CcSEcCtD
Tizanidine—Paraesthesia—Doxorubicin—liver cancer	0.000712	0.000793	CcSEcCtD
Tizanidine—Dyspnoea—Doxorubicin—liver cancer	0.000707	0.000788	CcSEcCtD
Tizanidine—Feeling abnormal—Epirubicin—liver cancer	0.000706	0.000787	CcSEcCtD
Tizanidine—Somnolence—Doxorubicin—liver cancer	0.000705	0.000786	CcSEcCtD
Tizanidine—Gastrointestinal pain—Epirubicin—liver cancer	0.000701	0.000781	CcSEcCtD
Tizanidine—Dyspepsia—Doxorubicin—liver cancer	0.000698	0.000778	CcSEcCtD
Tizanidine—Fatigue—Doxorubicin—liver cancer	0.000684	0.000762	CcSEcCtD
Tizanidine—Urticaria—Epirubicin—liver cancer	0.000681	0.000759	CcSEcCtD
Tizanidine—Constipation—Doxorubicin—liver cancer	0.000678	0.000756	CcSEcCtD
Tizanidine—Abdominal pain—Epirubicin—liver cancer	0.000678	0.000755	CcSEcCtD
Tizanidine—Body temperature increased—Epirubicin—liver cancer	0.000678	0.000755	CcSEcCtD
Tizanidine—Feeling abnormal—Doxorubicin—liver cancer	0.000654	0.000728	CcSEcCtD
Tizanidine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000649	0.000723	CcSEcCtD
Tizanidine—Hypersensitivity—Epirubicin—liver cancer	0.000632	0.000704	CcSEcCtD
Tizanidine—Urticaria—Doxorubicin—liver cancer	0.00063	0.000702	CcSEcCtD
Tizanidine—Abdominal pain—Doxorubicin—liver cancer	0.000627	0.000699	CcSEcCtD
Tizanidine—Body temperature increased—Doxorubicin—liver cancer	0.000627	0.000699	CcSEcCtD
Tizanidine—Asthenia—Epirubicin—liver cancer	0.000615	0.000685	CcSEcCtD
Tizanidine—Pruritus—Epirubicin—liver cancer	0.000607	0.000676	CcSEcCtD
Tizanidine—Diarrhoea—Epirubicin—liver cancer	0.000587	0.000653	CcSEcCtD
Tizanidine—Hypersensitivity—Doxorubicin—liver cancer	0.000584	0.000651	CcSEcCtD
Tizanidine—Asthenia—Doxorubicin—liver cancer	0.000569	0.000634	CcSEcCtD
Tizanidine—Dizziness—Epirubicin—liver cancer	0.000567	0.000632	CcSEcCtD
Tizanidine—Pruritus—Doxorubicin—liver cancer	0.000561	0.000625	CcSEcCtD
Tizanidine—Vomiting—Epirubicin—liver cancer	0.000545	0.000607	CcSEcCtD
Tizanidine—Diarrhoea—Doxorubicin—liver cancer	0.000543	0.000605	CcSEcCtD
Tizanidine—Rash—Epirubicin—liver cancer	0.000541	0.000602	CcSEcCtD
Tizanidine—Dermatitis—Epirubicin—liver cancer	0.00054	0.000602	CcSEcCtD
Tizanidine—Dizziness—Doxorubicin—liver cancer	0.000525	0.000584	CcSEcCtD
Tizanidine—Nausea—Epirubicin—liver cancer	0.000509	0.000567	CcSEcCtD
Tizanidine—Vomiting—Doxorubicin—liver cancer	0.000504	0.000562	CcSEcCtD
Tizanidine—Rash—Doxorubicin—liver cancer	0.0005	0.000557	CcSEcCtD
Tizanidine—Dermatitis—Doxorubicin—liver cancer	0.0005	0.000557	CcSEcCtD
Tizanidine—Nausea—Doxorubicin—liver cancer	0.000471	0.000525	CcSEcCtD
Tizanidine—CYP1A2—Metabolism—GLUL—liver cancer	5.54e-05	0.000548	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3CG—liver cancer	5.53e-05	0.000547	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—liver cancer	5.41e-05	0.000536	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—F2—liver cancer	5.4e-05	0.000534	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—VEGFA—liver cancer	5.38e-05	0.000533	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PIK3CD—liver cancer	5.35e-05	0.00053	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GSTP1—liver cancer	5.35e-05	0.000529	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NR1H4—liver cancer	5.34e-05	0.000528	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—TGFB1—liver cancer	5.29e-05	0.000523	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—HMOX1—liver cancer	5.28e-05	0.000522	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP2E1—liver cancer	5.27e-05	0.000521	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTA3—liver cancer	5.25e-05	0.000519	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CG—liver cancer	5.17e-05	0.000511	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—IL2—liver cancer	5.15e-05	0.000509	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADAM17—liver cancer	5.12e-05	0.000507	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PIK3CD—liver cancer	5e-05	0.000495	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—TGFB1—liver cancer	4.94e-05	0.000489	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYCS—liver cancer	4.93e-05	0.000488	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PRKCE—liver cancer	4.92e-05	0.000487	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GSTM1—liver cancer	4.92e-05	0.000486	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—KRAS—liver cancer	4.9e-05	0.000485	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3CD—liver cancer	4.86e-05	0.000481	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GGT1—liver cancer	4.84e-05	0.000479	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GOT1—liver cancer	4.84e-05	0.000479	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—F2—liver cancer	4.83e-05	0.000478	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PSMA4—liver cancer	4.82e-05	0.000477	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PSMD10—liver cancer	4.82e-05	0.000477	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTA4—liver cancer	4.8e-05	0.000475	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	4.69e-05	0.000464	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTA2—liver cancer	4.68e-05	0.000463	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PIK3CB—liver cancer	4.67e-05	0.000462	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CYP1A1—liver cancer	4.66e-05	0.000461	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IGF2—liver cancer	4.66e-05	0.000461	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CG—liver cancer	4.62e-05	0.000457	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PRKCE—liver cancer	4.59e-05	0.000455	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—KRAS—liver cancer	4.58e-05	0.000453	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CD—liver cancer	4.54e-05	0.000449	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTA1—liver cancer	4.51e-05	0.000447	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—PIK3CA—liver cancer	4.5e-05	0.000445	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NAT2—liver cancer	4.46e-05	0.000442	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—F2—liver cancer	4.38e-05	0.000434	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—VEGFA—liver cancer	4.37e-05	0.000433	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PIK3CB—liver cancer	4.36e-05	0.000431	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—TP53—liver cancer	4.36e-05	0.000431	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IGF2—liver cancer	4.35e-05	0.000431	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CSF2—liver cancer	4.35e-05	0.000431	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GSTP1—liver cancer	4.34e-05	0.00043	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—MTHFR—liver cancer	4.34e-05	0.00043	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—RAF1—liver cancer	4.34e-05	0.00043	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.29e-05	0.000425	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—H2AFX—liver cancer	4.29e-05	0.000424	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—IL2—liver cancer	4.29e-05	0.000424	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—HMOX1—liver cancer	4.28e-05	0.000424	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALDOB—liver cancer	4.28e-05	0.000423	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PPARA—liver cancer	4.26e-05	0.000422	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3CB—liver cancer	4.24e-05	0.000419	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—PIK3CA—liver cancer	4.21e-05	0.000416	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CG—liver cancer	4.2e-05	0.000415	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—HRAS—liver cancer	4.16e-05	0.000412	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CRABP1—liver cancer	4.08e-05	0.000404	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—TP53—liver cancer	4.07e-05	0.000403	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CSF2—liver cancer	4.06e-05	0.000402	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CD—liver cancer	4.06e-05	0.000402	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—RAF1—liver cancer	4.05e-05	0.000401	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TGFB1—liver cancer	4.01e-05	0.000397	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—H2AFX—liver cancer	4.01e-05	0.000396	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—IL2—liver cancer	4e-05	0.000396	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GSTM1—liver cancer	3.99e-05	0.000395	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CB—liver cancer	3.96e-05	0.000392	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL2—liver cancer	3.89e-05	0.000385	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—HRAS—liver cancer	3.89e-05	0.000385	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TERT—liver cancer	3.88e-05	0.000384	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP1A1—liver cancer	3.78e-05	0.000375	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PRKCE—liver cancer	3.73e-05	0.000369	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—KRAS—liver cancer	3.72e-05	0.000368	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CD—liver cancer	3.69e-05	0.000365	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—AKT1—liver cancer	3.68e-05	0.000364	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.67e-05	0.000364	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CG—liver cancer	3.65e-05	0.000361	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL2—liver cancer	3.64e-05	0.00036	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TERT—liver cancer	3.62e-05	0.000358	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HPGDS—liver cancer	3.57e-05	0.000353	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KDR—liver cancer	3.55e-05	0.000351	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.55e-05	0.000351	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CB—liver cancer	3.54e-05	0.00035	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IGF2—liver cancer	3.54e-05	0.00035	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—MTHFR—liver cancer	3.53e-05	0.000349	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MAPK14—liver cancer	3.52e-05	0.000349	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PPARG—liver cancer	3.52e-05	0.000349	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPARA—liver cancer	3.46e-05	0.000343	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ESR1—liver cancer	3.46e-05	0.000342	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—AKT1—liver cancer	3.44e-05	0.00034	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—PIK3CA—liver cancer	3.42e-05	0.000338	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—F2—liver cancer	3.41e-05	0.000338	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KDR—liver cancer	3.31e-05	0.000328	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—TP53—liver cancer	3.3e-05	0.000327	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CSF2—liver cancer	3.3e-05	0.000327	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—RAF1—liver cancer	3.29e-05	0.000326	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAPK14—liver cancer	3.29e-05	0.000326	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CG—liver cancer	3.27e-05	0.000323	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—APC—liver cancer	3.27e-05	0.000323	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—H2AFX—liver cancer	3.25e-05	0.000322	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—IL2—liver cancer	3.25e-05	0.000322	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.23e-05	0.00032	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ESR1—liver cancer	3.23e-05	0.000319	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CB—liver cancer	3.22e-05	0.000318	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CD—liver cancer	3.21e-05	0.000317	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—F2—liver cancer	3.19e-05	0.000316	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.19e-05	0.000316	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PSMA4—liver cancer	3.18e-05	0.000315	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PSMD10—liver cancer	3.18e-05	0.000315	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—ALB—liver cancer	3.17e-05	0.000313	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—HRAS—liver cancer	3.16e-05	0.000313	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GOT2—liver cancer	3.09e-05	0.000306	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—BRAF—liver cancer	3.07e-05	0.000304	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—APC—liver cancer	3.05e-05	0.000302	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CG—liver cancer	3.05e-05	0.000302	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CG—liver cancer	2.96e-05	0.000293	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL2—liver cancer	2.95e-05	0.000292	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TERT—liver cancer	2.94e-05	0.000291	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP2E1—liver cancer	2.91e-05	0.000288	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CD—liver cancer	2.87e-05	0.000284	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—BRAF—liver cancer	2.87e-05	0.000284	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPARG—liver cancer	2.86e-05	0.000283	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—PIK3CA—liver cancer	2.84e-05	0.000282	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SERPINE1—liver cancer	2.84e-05	0.000281	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.82e-05	0.000279	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—KRAS—liver cancer	2.81e-05	0.000278	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CB—liver cancer	2.8e-05	0.000277	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—AKT1—liver cancer	2.79e-05	0.000276	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYCS—liver cancer	2.72e-05	0.000269	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KDR—liver cancer	2.69e-05	0.000266	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CD—liver cancer	2.68e-05	0.000265	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAPK14—liver cancer	2.67e-05	0.000265	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GOT1—liver cancer	2.67e-05	0.000264	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GGT1—liver cancer	2.67e-05	0.000264	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—PIK3CA—liver cancer	2.66e-05	0.000263	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SERPINE1—liver cancer	2.65e-05	0.000263	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—KRAS—liver cancer	2.63e-05	0.00026	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ESR1—liver cancer	2.62e-05	0.000259	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CD—liver cancer	2.61e-05	0.000258	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—F2—liver cancer	2.59e-05	0.000256	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—PIK3CA—liver cancer	2.58e-05	0.000256	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—ALB—liver cancer	2.57e-05	0.000255	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RAF1—liver cancer	2.56e-05	0.000254	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CB—liver cancer	2.5e-05	0.000248	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MTOR—liver cancer	2.5e-05	0.000248	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—APC—liver cancer	2.48e-05	0.000245	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CG—liver cancer	2.48e-05	0.000245	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—PIK3CA—liver cancer	2.41e-05	0.000239	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTP1—liver cancer	2.4e-05	0.000237	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RAF1—liver cancer	2.4e-05	0.000237	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—HRAS—liver cancer	2.39e-05	0.000237	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HMOX1—liver cancer	2.37e-05	0.000234	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CDKN1B—liver cancer	2.35e-05	0.000232	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MTOR—liver cancer	2.34e-05	0.000231	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CB—liver cancer	2.34e-05	0.000231	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—BRAF—liver cancer	2.33e-05	0.000231	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—AKT1—liver cancer	2.32e-05	0.00023	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CASP3—liver cancer	2.3e-05	0.000228	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL2—liver cancer	2.3e-05	0.000227	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL6—liver cancer	2.29e-05	0.000226	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CB—liver cancer	2.27e-05	0.000225	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CCND1—liver cancer	2.24e-05	0.000222	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—JUN—liver cancer	2.24e-05	0.000221	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—HRAS—liver cancer	2.23e-05	0.000221	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CTNNB1—liver cancer	2.22e-05	0.00022	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GSTM1—liver cancer	2.2e-05	0.000218	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CDKN1B—liver cancer	2.19e-05	0.000217	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CD—liver cancer	2.18e-05	0.000216	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MMP9—liver cancer	2.18e-05	0.000215	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—AKT1—liver cancer	2.17e-05	0.000215	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—CDKN1A—liver cancer	2.17e-05	0.000215	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—PIK3CA—liver cancer	2.16e-05	0.000214	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SERPINE1—liver cancer	2.16e-05	0.000213	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CASP3—liver cancer	2.15e-05	0.000213	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL2—liver cancer	2.15e-05	0.000213	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL6—liver cancer	2.14e-05	0.000211	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—KRAS—liver cancer	2.13e-05	0.000211	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MAPK8—liver cancer	2.12e-05	0.000209	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—AKT1—liver cancer	2.11e-05	0.000209	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CCND1—liver cancer	2.09e-05	0.000207	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP1A1—liver cancer	2.09e-05	0.000207	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—JUN—liver cancer	2.09e-05	0.000207	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CTNNB1—liver cancer	2.07e-05	0.000205	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MMP9—liver cancer	2.03e-05	0.000201	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—CDKN1A—liver cancer	2.03e-05	0.0002	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MAPK8—liver cancer	1.98e-05	0.000196	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—AKT1—liver cancer	1.97e-05	0.000195	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—PIK3CA—liver cancer	1.96e-05	0.000194	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—VEGFA—liver cancer	1.95e-05	0.000193	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—MTHFR—liver cancer	1.95e-05	0.000193	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RAF1—liver cancer	1.95e-05	0.000193	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—STAT3—liver cancer	1.93e-05	0.000191	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARA—liver cancer	1.91e-05	0.000189	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CB—liver cancer	1.9e-05	0.000188	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MTOR—liver cancer	1.9e-05	0.000188	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—VEGFA—liver cancer	1.83e-05	0.000181	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—HRAS—liver cancer	1.81e-05	0.000179	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—STAT3—liver cancer	1.81e-05	0.000179	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MYC—liver cancer	1.8e-05	0.000178	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TGFB1—liver cancer	1.79e-05	0.000177	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CDKN1B—liver cancer	1.78e-05	0.000176	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AKT1—liver cancer	1.76e-05	0.000174	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CASP3—liver cancer	1.75e-05	0.000173	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL2—liver cancer	1.74e-05	0.000173	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6—liver cancer	1.74e-05	0.000172	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.72e-05	0.00017	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PIK3CA—liver cancer	1.7e-05	0.000169	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CCND1—liver cancer	1.7e-05	0.000168	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—JUN—liver cancer	1.7e-05	0.000168	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CTNNB1—liver cancer	1.68e-05	0.000167	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MYC—liver cancer	1.68e-05	0.000166	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TGFB1—liver cancer	1.68e-05	0.000166	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—KRAS—liver cancer	1.66e-05	0.000164	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MMP9—liver cancer	1.65e-05	0.000163	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—CDKN1A—liver cancer	1.65e-05	0.000163	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CG—liver cancer	1.64e-05	0.000162	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MAPK8—liver cancer	1.61e-05	0.000159	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AKT1—liver cancer	1.6e-05	0.000158	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARG—liver cancer	1.58e-05	0.000156	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—KRAS—liver cancer	1.55e-05	0.000154	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PIK3CA—liver cancer	1.53e-05	0.000151	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—VEGFA—liver cancer	1.48e-05	0.000147	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TP53—liver cancer	1.48e-05	0.000146	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—STAT3—liver cancer	1.47e-05	0.000145	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CD—liver cancer	1.44e-05	0.000142	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PIK3CA—liver cancer	1.43e-05	0.000141	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ALB—liver cancer	1.42e-05	0.000141	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—HRAS—liver cancer	1.41e-05	0.00014	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—AKT1—liver cancer	1.39e-05	0.000138	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PIK3CA—liver cancer	1.38e-05	0.000137	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TP53—liver cancer	1.38e-05	0.000136	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MYC—liver cancer	1.36e-05	0.000135	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TGFB1—liver cancer	1.36e-05	0.000135	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6—liver cancer	1.35e-05	0.000134	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—HRAS—liver cancer	1.32e-05	0.000131	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6—liver cancer	1.26e-05	0.000125	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—KRAS—liver cancer	1.26e-05	0.000125	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CB—liver cancer	1.25e-05	0.000124	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKT1—liver cancer	1.25e-05	0.000123	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKT1—liver cancer	1.16e-05	0.000115	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PIK3CA—liver cancer	1.16e-05	0.000115	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AKT1—liver cancer	1.13e-05	0.000112	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TP53—liver cancer	1.12e-05	0.000111	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—HRAS—liver cancer	1.07e-05	0.000106	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6—liver cancer	1.03e-05	0.000101	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKT1—liver cancer	9.46e-06	9.36e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PIK3CA—liver cancer	7.64e-06	7.56e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AKT1—liver cancer	6.24e-06	6.18e-05	CbGpPWpGaD
